Apexigen, Inc. Operating Income
Apexigen, Inc. reported Operating Income of -$6.16 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-08-10
- Apexigen, Inc. operating income (loss) for the quarter ending 2023-06-30 was -$6.16M.
- Apexigen, Inc. operating income (loss) for the quarter ending 2023-03-31 was -$6.22M.
- Apexigen, Inc. operating income (loss) for the quarter ending 2022-12-31 was -$6.65M.
- Apexigen, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$8.80M.
- Apexigen, Inc. operating income (loss) for fiscal 2022 was -$32.69M.
- Apexigen, Inc. operating income (loss) for fiscal 2021 was -$28.96M.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 4 month | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 7 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$6.16M 10-Q · filed 2023-08-10 | -$12.37M 10-Q · filed 2023-08-10 | -$19.02M derived: sum of 3 quarters · filed 2023-08-10 | -$27.82M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2023-03-31 | -$6.22M 10-Q · filed 2023-05-15 | -$12.87M derived: sum of 2 quarters · filed 2023-05-15 | -$21.66M derived: sum of 3 quarters · filed 2023-05-15 | -$29.81M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-12-31 | -$6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$15.45M derived: sum of 2 quarters · filed 2023-02-22 | -$23.59M derived: sum of 3 quarters · filed 2023-08-10 | -$32.69M 10-K · filed 2023-02-22 | |||||||
| 2022-09-30 | -$8.80M 10-Q · filed 2022-11-14 | -$16.94M derived: sum of 2 quarters · filed 2023-08-10 | -$26.04M 10-Q · filed 2022-11-14 | -$34.14M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-06-30 | -$8.14M 10-Q · filed 2023-08-10 | -$1.78M 10-Q · filed 2022-08-18 | -$17.24M 10-Q · filed 2023-08-10 | -$4.24M 10-Q · filed 2022-08-18 | -$25.34M derived: sum of 3 quarters · filed 2023-08-10 | -$32.65M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | -$9.09M 10-Q · filed 2023-05-15 | -$2.46M 10-Q · filed 2022-05-23 | -$17.19M derived: sum of 2 quarters · filed 2023-05-15 | -$24.50M derived: sum of 3 quarters · filed 2023-05-15 | -$24.67M derived: sum of 4 quarters · filed 2023-05-15 | ||||||
| 2021-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$15.41M derived: sum of 2 quarters · filed 2023-02-22 | -$15.57M derived: sum of 3 quarters · filed 2023-02-22 | -$28.96M 10-K · filed 2023-02-22 | -$603.18K 10-K · filed 2022-04-07 | ||||||
| 2021-09-30 | -$7.31M 10-Q · filed 2022-11-14 | -$166.00K 10-Q · filed 2021-12-09 | -$7.47M derived: sum of 2 quarters · filed 2022-11-14 | -$20.86M 10-Q · filed 2022-11-14 | -$452.21K 10-Q · filed 2021-12-09 | ||||||
| 2021-06-30 | -$163.52K 10-Q · filed 2022-08-18 | -$286.21K 10-Q · filed 2022-08-18 | |||||||||
| 2021-03-31 | -$122.69K 10-Q · filed 2022-05-23 | ||||||||||
| 2020-12-31 | -$1.83K 10-K · filed 2022-04-07 | ||||||||||
| 2020-09-30 | -$1.10K 10-Q · filed 2021-12-09 | -$1.83K 10-Q · filed 2021-12-09 | |||||||||
| 2020-06-30 | -$729.00 10-Q · filed 2021-08-16 |